BioHealth News

William E. Bentley, Professor of Engineering and Founding Director of the Fischell Institute for Biomedical Devices joins Rich Bendis for the first BioTalk of 2019

William E. Bentley, Professor of Engineering and Founding Director of the Fischell Institute for Biomedical Devices joins Rich Bendis for the first BioTalk of 2019

William E. Bentley is the Robert E. Fischell Distinguished Chair of Engineering and the Inaugural Director of the Robert E. Fischell Institute for Biomedical…

Read More
Gemstone Biotherapeutics CEO Emily English joins Rich Bendis on BioTalk

Gemstone Biotherapeutics CEO Emily English joins Rich Bendis on BioTalk

Emily English, CEO of Gemstone Biotherapeutics sits down with BioTalk host Rich Bendis to discuss company's history, the path to her role, and the…

Read More
La Petite Noiseuse Productions Co-Founder and Chief Science and Art Officer Monica Lopez, PhD joins Rich Bendis on BioTalk

La Petite Noiseuse Productions Co-Founder and Chief Science and Art Officer Monica Lopez, PhD joins Rich Bendis on BioTalk

Correction: This story originally published on 10/16 included a 2nd paragraph referencing a previous guest of BioTalk and not Monica Lopez, PhDLa Petite Noiseuse…

Read More
Brian Darmody, UMD Associate VP of Corporate Engagement, joins Rich Bendis on BioTalk

Brian Darmody, UMD Associate VP of Corporate Engagement, joins Rich Bendis on BioTalk

In this episode of BioTalk, Rich Bendis and guest Brian Darmody discuss growth across the region, the battle for talent and the upcoming AURP…

Read More
Virginia Bio CEO Jeff Gallagher joins Rich Bendis on BioTalk

Virginia Bio CEO Jeff Gallagher joins Rich Bendis on BioTalk

Jeff Gallagher, CEO of Virginia Bio sits down with BioTalk host Rich Bendis to discuss accomplishments, challenges, and initiatives in his state and the…

Read More
Immunomic Therapeutics, Inc. Founder and CEO Bill Hearl Joins Rich Bendis for BioTalk

Immunomic Therapeutics, Inc. Founder and CEO Bill Hearl Joins Rich Bendis for BioTalk

Dr. Bill Hearl is the Founder and Chief Executive Officer of Immunomic Therapeutics, Inc. (“ITI”).  He is an experienced and successful scientific businessman and…

Read More
Matt Mulvey, Co-Founder and CEO of BeneVir, sits down with host Rich Bendis to discuss Funding, Licensing, and their new relationship with J&J

Matt Mulvey, Co-Founder and CEO of BeneVir, sits down with host Rich Bendis to discuss Funding, Licensing, and their new relationship with J&J

Matt holds a Ph.D. in Virology from Ian Mohr’s lab at NYU Langone Medical Center.  He is also an inventor on all BeneVir patents…

Read More
Brian Gaines, Chief Executive Officer of the MdBio Foundation, joins BioTalk host Rich Bendis to discuss STEM Education, Workforce Development, Funding, and expanding beyond the BioHealth Capital Region

Brian Gaines, Chief Executive Officer of the MdBio Foundation, joins BioTalk host Rich Bendis to discuss STEM Education, Workforce Development, Funding, and expanding beyond the BioHealth Capital Region

Brian joined the MdBio Foundation in November 2012 after serving as Executive Director of the Washington Redskins Charitable Foundation. He has spent most of…

Read More
Jeff Galvin, CEO & Founder, American Gene Technologies (AGT), joins Rich Bendis on BioTalk

Jeff Galvin, CEO & Founder, American Gene Technologies (AGT), joins Rich Bendis on BioTalk

In this episode of BioTalk, Jeff Galvin, CEO & Founder of American Gene Technologies (AGT) joins host Rich Bendis to discuss genetic medicines, funding…

Read More
Quality Biological, Inc. (QBI) President and CEO Angela  Graham joins Rich Bendis for New Episode of BioTalk

Quality Biological, Inc. (QBI) President and CEO Angela Graham joins Rich Bendis for New Episode of BioTalk

Angela Graham, President and CEO of Quality Biological, Inc. (QBI), joins BioTalk host Rich Bendis to discuss growing a business in the Life Sciences…

Read More
Rip Ballou, MD, VP & Head, GSK Global Vaccines US R&D Center, joins host Rich Bendis on a new episode of BioTalk

Rip Ballou, MD, VP & Head, GSK Global Vaccines US R&D Center, joins host Rich Bendis on a new episode of BioTalk

In this new episode of BioTalk, Rip Ballou, MD, VP & Head, GSK Global Vaccines US R&D Center and BHI President & CEO Rich…

Read More
Matt Brady, Vice President at Scheer Partners, chats with host Rich Bendis on BioTalk

Matt Brady, Vice President at Scheer Partners, chats with host Rich Bendis on BioTalk

In this new episode of BioTalk, Matt Brady and BHI President & CEO Rich Bendis discuss topics around lab spaces in the area including,…

Read More
Margaret Anderson, Managing Director at Deloitte Consulting LLP, sits down with host Rich Bendis for this episode of BioTalk. They discuss her career path, putting patients at the center of biomedical and public health, and engaging with all sectors. Marg

Margaret Anderson, Managing Director at Deloitte Consulting LLP, sits down with host Rich Bendis for this episode of BioTalk. They discuss her career path, putting patients at the center of biomedical and public health, and engaging with all sectors. Marg

Margaret Anderson, Managing Director at Deloitte Consulting LLP, sits down with host Rich Bendis for this episode of BioTalk. They discuss her career path,…

Read More
Live from the BioHealth Capital Region Forum – Part 2: Todd Haim, SBIR Director, NCI SBIR Development Center at NIH, and Matthew McMahon, Director, Office of Translational Alliances and Coordination at the National Heart, Lung, and Blood Institute at NIH

Live from the BioHealth Capital Region Forum – Part 2: Todd Haim, SBIR Director, NCI SBIR Development Center at NIH, and Matthew McMahon, Director, Office of Translational Alliances and Coordination at the National Heart, Lung, and Blood Institute at NIH

In this second part of two episodes, Rich sits down with leaders from different parts of the BHCR to talk about what they are…

Read More
Live from the BioHealth Capital Region Forum – Part 1: Jim Jackson, SVP, CSO at Emergent BioSolutions and Jim Hughes, Vice President at University of Maryland, Baltimore

Live from the BioHealth Capital Region Forum – Part 1: Jim Jackson, SVP, CSO at Emergent BioSolutions and Jim Hughes, Vice President at University of Maryland, Baltimore

In this first part of two episodes, Rich sits down with leaders from different parts of the BHCR to talk about what they are…

Read More